2009
DOI: 10.2165/11314700-000000000-00000
|View full text |Cite
|
Sign up to set email alerts
|

The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US

Abstract: Studies have not previously reported the indirect cost burden of multiple sclerosis (MS) from an employer perspective. To compare annual indirect costs between privately insured US employees with MS and matched employee controls. A retrospective analysis of a privately insured claims database containing disability data from 17 US companies was conducted. Employees with >/=1 MS diagnosis (ICD-9-CM: 340.x) after 1 January 2002, aged 18-64 years, were selected. Employees with MS were matched by age and sex to emp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
54
0
3

Year Published

2010
2010
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 69 publications
(57 citation statements)
references
References 30 publications
(39 reference statements)
0
54
0
3
Order By: Relevance
“…Fatigue, impaired cognition, neurological, psychological and overall symptoms, relapses requiring hospitalization and absenteeism among such patients may render the working environment not adaptable to their needs. A recent study carried out in the United States showed that MS poses a significant burden on employers, with indirect costs due to absenteeism and disability requirements for these patients at work of more than US$ 4,000 per patient per year 16 . In Canada, MS patients over the age of 39 years who are still employed are at risk of becoming unemployed in the next 2.5 years 17 .…”
Section: Discussionmentioning
confidence: 99%
“…Fatigue, impaired cognition, neurological, psychological and overall symptoms, relapses requiring hospitalization and absenteeism among such patients may render the working environment not adaptable to their needs. A recent study carried out in the United States showed that MS poses a significant burden on employers, with indirect costs due to absenteeism and disability requirements for these patients at work of more than US$ 4,000 per patient per year 16 . In Canada, MS patients over the age of 39 years who are still employed are at risk of becoming unemployed in the next 2.5 years 17 .…”
Section: Discussionmentioning
confidence: 99%
“…Lifetime health-care costs for treating one patient with MS were estimated to be US$3.4 million, 7 and one Australian study estimated that almost half the costs associated with MS could be attributed to loss of productivity. 8 In another report, the indirect costs associated with employed patients with MS, including disability and absenteeism, were more than four times higher than those of their counterparts without MS. 9 Berlin, Germany). Interviews were conducted until saturation of concepts was reached.…”
mentioning
confidence: 99%
“…Total annual indirect costs for employees with MS were $5,769 compared with annual costs of other employees at $1,417. 13 Pharmacotherapy contributes significantly to the costs of treating MS. The newer DMT agents, such as the first approved oral DMT agent, fingolimod, have significantly higher costs than those of competing first-line treatments, such as injectable biological agents.…”
Section: Ms = Multiple Sclerosismentioning
confidence: 99%